4//SEC Filing
Cox Aaron 4
Accession 0001209191-23-003623
CIK 0001492426other
Filed
Jan 16, 7:00 PM ET
Accepted
Jan 17, 8:32 PM ET
Size
5.5 KB
Accession
0001209191-23-003623
Insider Transaction Report
Form 4
Cox Aaron
EVP, Chief Financial Officer
Transactions
- Sale
Ordinary Shares
2023-01-13$113.17/sh−36,148$4,090,847→ 277 total
Footnotes (2)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2022.
- [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.12 to $113.21 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Horizon Therapeutics Public Ltd Co
CIK 0001492426
Entity typeother
Related Parties
1- filerCIK 0001924351
Filing Metadata
- Form type
- 4
- Filed
- Jan 16, 7:00 PM ET
- Accepted
- Jan 17, 8:32 PM ET
- Size
- 5.5 KB